Nicolas Venisse

Summary

Affiliation: CHU de Poitiers
Country: France

Publications

  1. ncbi request reprint [Level of evidence for therapeutic drug monitoring of fluconazole]
    Nicolas Venisse
    Service de Toxicologie et Pharmacocinétique, CHU Poitiers, Poitiers, France
    Therapie 66:97-101. 2011
  2. ncbi request reprint [Level of evidence for therapeutic drug monitoring of aminoglycosides]
    Nicolas Venisse
    Service de Toxicologie et Pharmacocinétique, CHU, Poitiers, France
    Therapie 66:39-44. 2011

Collaborators

Detail Information

Publications2

  1. ncbi request reprint [Level of evidence for therapeutic drug monitoring of fluconazole]
    Nicolas Venisse
    Service de Toxicologie et Pharmacocinétique, CHU Poitiers, Poitiers, France
    Therapie 66:97-101. 2011
    ..Concentration-efficacy relationships are demonstrated whereas concentration-toxicity relationships are sparse. As a consequence, therapeutic drug monitoring is not routinely recommended but can be useful in certain situations...
  2. ncbi request reprint [Level of evidence for therapeutic drug monitoring of aminoglycosides]
    Nicolas Venisse
    Service de Toxicologie et Pharmacocinétique, CHU, Poitiers, France
    Therapie 66:39-44. 2011
    ..Therefore TDM of aminoglycosides should be considered "essential". Level of evidence for TDM of aminoglycosides administered once daily is not so clearly demonstrated however it should be highly recommended...